Skip to main content
Erschienen in: Endocrine 1/2014

01.09.2014 | Original Article

Can increased tumoral vascularity be a quantitative predicting factor of lymph node metastasis in papillary thyroid microcarcinoma?

verfasst von: Hyun Joo Shin, Eun-Kyung Kim, Hee Jung Moon, Jung Hyun Yoon, Kyung Hwa Han, Jin Young Kwak

Erschienen in: Endocrine | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

The aim of the present study was to evaluate the clinical implications of the vascular index (VI) as a predicting factor for central and lateral lymph node metastasis (LNM) in patients with papillary thyroid microcarcinoma (PTMC). From January 2011 to October 2011, 588 patients (495 females, 93 males) who were diagnosed with PTMC were included. Clinicopathologic characteristics of patients and ultrasound (US) features of the lesions including VI were evaluated retrospectively. The VI was measured with QLAB 7.0 quantification software using preoperative Doppler US images. Univariate and multivariate analysis were used to assess predictive factors of LNM. From 588 patients, 140 patients (23.8 %) had central LNM and 26 patients (4.4 %) had lateral LNM on pathologic results. The presence of lateral LNM [odds ratio (OR) 5.46; 95 % confidence interval (CI) = 2.19–13.64], bilaterality (OR 2.16; 95 % CI 1.17–4.01), and increased tumor size (OR 1.15; 95 % CI 1.04–1.28) were significant independent factors for predicting central LNM. The presence of central LNM (OR 5.58; 95 % CI 2.22–14.04), upper third location of malignancy (OR 2.50; 95 % CI 1.01–6.21), and tumor size (OR 1.34; 95 % CI 1.03–1.73) were significant independent factors for predicting lateral LNM. However, the VI was not a significant predicting factor for both central and lateral LNM. Therefore, the VI of PTMC may not be useful for predicting central and lateral LNM in patients with PTMC.
Literatur
1.
Zurück zum Zitat H.R. Shin, K.W. Jung, Y.J. Won, J.G. Park, K.-A. Hospitals, 2002 Annual report of the Korea Central Cancer Registry: based on registered data from 139 hospitals. Cancer Res. Treat. 36(2), 103–114 (2004)PubMedCrossRefPubMedCentral H.R. Shin, K.W. Jung, Y.J. Won, J.G. Park, K.-A. Hospitals, 2002 Annual report of the Korea Central Cancer Registry: based on registered data from 139 hospitals. Cancer Res. Treat. 36(2), 103–114 (2004)PubMedCrossRefPubMedCentral
2.
Zurück zum Zitat M.D. Bramley, B.J. Harrison, Papillary microcarcinoma of the thyroid gland. Br. J. Surg. 83(12), 1674–1683 (1996)PubMedCrossRef M.D. Bramley, B.J. Harrison, Papillary microcarcinoma of the thyroid gland. Br. J. Surg. 83(12), 1674–1683 (1996)PubMedCrossRef
3.
Zurück zum Zitat H.R. Harach, K.O. Franssila, V.M. Wasenius, Occult papillary carcinoma of the thyroid. A “normal” finding in Finland. A systematic autopsy study. Cancer 56(3), 531–538 (1985)PubMedCrossRef H.R. Harach, K.O. Franssila, V.M. Wasenius, Occult papillary carcinoma of the thyroid. A “normal” finding in Finland. A systematic autopsy study. Cancer 56(3), 531–538 (1985)PubMedCrossRef
4.
Zurück zum Zitat J.Y. Kwak, E.K. Kim, M.J. Kim, E.J. Son, W.Y. Chung, C.S. Park, K.H. Nam, Papillary microcarcinoma of the thyroid: predicting factors of lateral neck node metastasis. Ann. Surg. Oncol. 16(5), 1348–1355 (2009)PubMedCrossRef J.Y. Kwak, E.K. Kim, M.J. Kim, E.J. Son, W.Y. Chung, C.S. Park, K.H. Nam, Papillary microcarcinoma of the thyroid: predicting factors of lateral neck node metastasis. Ann. Surg. Oncol. 16(5), 1348–1355 (2009)PubMedCrossRef
5.
Zurück zum Zitat J.Y. Kwak, E.K. Kim, W.Y. Chung, H.J. Moon, M.J. Kim, J.R. Choi, Association of BRAFV600E mutation with poor clinical prognostic factors and US features in Korean patients with papillary thyroid microcarcinoma. Radiology 253(3), 854–860 (2009)PubMedCrossRef J.Y. Kwak, E.K. Kim, W.Y. Chung, H.J. Moon, M.J. Kim, J.R. Choi, Association of BRAFV600E mutation with poor clinical prognostic factors and US features in Korean patients with papillary thyroid microcarcinoma. Radiology 253(3), 854–860 (2009)PubMedCrossRef
6.
Zurück zum Zitat S.S. Kim, B.J. Lee, J.C. Lee, S.J. Kim, S.H. Lee, Y.K. Jeon, B.H. Kim, Y.K. Kim, I.J. Kim, Preoperative ultrasonographic tumor characteristics as a predictive factor of tumor stage in papillary thyroid carcinoma. Head Neck 33(12), 1719–1726 (2011)PubMedCrossRef S.S. Kim, B.J. Lee, J.C. Lee, S.J. Kim, S.H. Lee, Y.K. Jeon, B.H. Kim, Y.K. Kim, I.J. Kim, Preoperative ultrasonographic tumor characteristics as a predictive factor of tumor stage in papillary thyroid carcinoma. Head Neck 33(12), 1719–1726 (2011)PubMedCrossRef
7.
Zurück zum Zitat J.S. Choi, J. Kim, J.Y. Kwak, M.J. Kim, H.S. Chang, E.K. Kim, Preoperative staging of papillary thyroid carcinoma: comparison of ultrasound imaging and CT. AJR Am. J. Roentgenol. 193(3), 871–878 (2009)PubMedCrossRef J.S. Choi, J. Kim, J.Y. Kwak, M.J. Kim, H.S. Chang, E.K. Kim, Preoperative staging of papillary thyroid carcinoma: comparison of ultrasound imaging and CT. AJR Am. J. Roentgenol. 193(3), 871–878 (2009)PubMedCrossRef
8.
Zurück zum Zitat Y. Ito, C. Tomoda, T. Uruno, Y. Takamura, A. Miya, K. Kobayashi, F. Matsuzuka, K. Kuma, A. Miyauchi, Preoperative ultrasonographic examination for lymph node metastasis: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid. World J. Surg. 28(5), 498–501 (2004)PubMedCrossRef Y. Ito, C. Tomoda, T. Uruno, Y. Takamura, A. Miya, K. Kobayashi, F. Matsuzuka, K. Kuma, A. Miyauchi, Preoperative ultrasonographic examination for lymph node metastasis: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid. World J. Surg. 28(5), 498–501 (2004)PubMedCrossRef
9.
Zurück zum Zitat S.S. Kim, B.J. Lee, J.C. Lee, S.H. Song, B.H. Kim, S.M. Son, I.J. Kim, Y.K. Kim, Y.H. Kang, Preoperative serum thyroid stimulating hormone levels in well-differentiated thyroid carcinoma is a predictive factor for lateral lymph node metastasis as well as extrathyroidal extension in Korean patients: a single-center experience. Endocrine 39(3), 259–265 (2011)PubMedCrossRef S.S. Kim, B.J. Lee, J.C. Lee, S.H. Song, B.H. Kim, S.M. Son, I.J. Kim, Y.K. Kim, Y.H. Kang, Preoperative serum thyroid stimulating hormone levels in well-differentiated thyroid carcinoma is a predictive factor for lateral lymph node metastasis as well as extrathyroidal extension in Korean patients: a single-center experience. Endocrine 39(3), 259–265 (2011)PubMedCrossRef
10.
Zurück zum Zitat C. Eloy, J. Santos, P. Soares, M. Sobrinho-Simoes, Intratumoural lymph vessel density is related to presence of lymph node metastases and separates encapsulated from infiltrative papillary thyroid carcinoma. Virchows Arch. 459(6), 595–605 (2011)PubMedCrossRef C. Eloy, J. Santos, P. Soares, M. Sobrinho-Simoes, Intratumoural lymph vessel density is related to presence of lymph node metastases and separates encapsulated from infiltrative papillary thyroid carcinoma. Virchows Arch. 459(6), 595–605 (2011)PubMedCrossRef
11.
Zurück zum Zitat J.Y. Kwak, E.K. Kim, M.J. Kim, S.H. Choi, E. Son, K.K. Oh, Power Doppler sonography: evaluation of solid breast lesions and correlation with lymph node metastasis. Clin. Imaging 32(3), 167–171 (2008)PubMedCrossRef J.Y. Kwak, E.K. Kim, M.J. Kim, S.H. Choi, E. Son, K.K. Oh, Power Doppler sonography: evaluation of solid breast lesions and correlation with lymph node metastasis. Clin. Imaging 32(3), 167–171 (2008)PubMedCrossRef
12.
Zurück zum Zitat K. Lee, J. Park do, G. Choe, H.H. Kim, W.H. Kim, H.S. Lee, Increased intratumoral lymphatic vessel density correlates with lymph node metastasis in early gastric carcinoma. Ann. Surg. Oncol. 17(1), 73–80 (2010)PubMedCrossRef K. Lee, J. Park do, G. Choe, H.H. Kim, W.H. Kim, H.S. Lee, Increased intratumoral lymphatic vessel density correlates with lymph node metastasis in early gastric carcinoma. Ann. Surg. Oncol. 17(1), 73–80 (2010)PubMedCrossRef
13.
Zurück zum Zitat J. Folkman, E. Merler, C. Abernathy, G. Williams, Isolation of a tumor factor responsible for angiogenesis. J. Exp. Med. 133(2), 275–288 (1971)PubMedCrossRefPubMedCentral J. Folkman, E. Merler, C. Abernathy, G. Williams, Isolation of a tumor factor responsible for angiogenesis. J. Exp. Med. 133(2), 275–288 (1971)PubMedCrossRefPubMedCentral
14.
Zurück zum Zitat J. Folkman, The role of angiogenesis in tumor growth. Semin. Cancer Biol. 3(2), 65–71 (1992)PubMed J. Folkman, The role of angiogenesis in tumor growth. Semin. Cancer Biol. 3(2), 65–71 (1992)PubMed
15.
Zurück zum Zitat A. Sternberg, M. Amar, R. Alfici, G. Groisman, Conclusions from a study of venous invasion in stage IV colorectal adenocarcinoma. J. Clin. Pathol. 55(1), 17–21 (2002)PubMedCrossRefPubMedCentral A. Sternberg, M. Amar, R. Alfici, G. Groisman, Conclusions from a study of venous invasion in stage IV colorectal adenocarcinoma. J. Clin. Pathol. 55(1), 17–21 (2002)PubMedCrossRefPubMedCentral
16.
Zurück zum Zitat N. Lassau, M. Lamuraglia, S. Koscielny, A. Spatz, A. Roche, J. Leclere, M.F. Avril, Prognostic value of angiogenesis evaluated with high-frequency and colour Doppler sonography for preoperative assessment of primary cutaneous melanomas: correlation with recurrence after a 5 year follow-up period. Cancer Imaging 6, 24–29 (2006)PubMedCrossRefPubMedCentral N. Lassau, M. Lamuraglia, S. Koscielny, A. Spatz, A. Roche, J. Leclere, M.F. Avril, Prognostic value of angiogenesis evaluated with high-frequency and colour Doppler sonography for preoperative assessment of primary cutaneous melanomas: correlation with recurrence after a 5 year follow-up period. Cancer Imaging 6, 24–29 (2006)PubMedCrossRefPubMedCentral
17.
Zurück zum Zitat C.N. Chen, Y.M. Cheng, M.T. Lin, F.J. Hsieh, P.H. Lee, K.J. Chang, Association of color Doppler vascularity index and microvessel density with survival in patients with gastric cancer. Ann. Surg. 235(4), 512–518 (2002)PubMedCrossRefPubMedCentral C.N. Chen, Y.M. Cheng, M.T. Lin, F.J. Hsieh, P.H. Lee, K.J. Chang, Association of color Doppler vascularity index and microvessel density with survival in patients with gastric cancer. Ann. Surg. 235(4), 512–518 (2002)PubMedCrossRefPubMedCentral
18.
Zurück zum Zitat C.A. Cuenod, L. Fournier, D. Balvay, J.M. Guinebretiere, Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment. Abdom. Imaging 31(2), 188–193 (2006)PubMedCrossRef C.A. Cuenod, L. Fournier, D. Balvay, J.M. Guinebretiere, Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment. Abdom. Imaging 31(2), 188–193 (2006)PubMedCrossRef
19.
Zurück zum Zitat S. Rehman, G.C. Jayson, Molecular imaging of antiangiogenic agents. Oncologist 10(2), 92–103 (2005)PubMedCrossRef S. Rehman, G.C. Jayson, Molecular imaging of antiangiogenic agents. Oncologist 10(2), 92–103 (2005)PubMedCrossRef
20.
Zurück zum Zitat Y. Takahashi, Y. Kitadai, C.D. Bucana, K.R. Cleary, L.M. Ellis, Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res. 55(18), 3964–3968 (1995)PubMed Y. Takahashi, Y. Kitadai, C.D. Bucana, K.R. Cleary, L.M. Ellis, Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res. 55(18), 3964–3968 (1995)PubMed
21.
Zurück zum Zitat N. Tanigawa, H. Amaya, M. Matsumura, T. Shimomatsuya, Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma. J. Clin. Oncol. 15(2), 826–832 (1997)PubMed N. Tanigawa, H. Amaya, M. Matsumura, T. Shimomatsuya, Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma. J. Clin. Oncol. 15(2), 826–832 (1997)PubMed
22.
Zurück zum Zitat W.W. Zhan, P. Zhou, J.Q. Zhou, S.Y. Xu, K.M. Chen, Differences in sonographic features of papillary thyroid carcinoma between neck lymph node metastatic and nonmetastatic groups. J. Ultrasound Med. 31(6), 915–920 (2012)PubMed W.W. Zhan, P. Zhou, J.Q. Zhou, S.Y. Xu, K.M. Chen, Differences in sonographic features of papillary thyroid carcinoma between neck lymph node metastatic and nonmetastatic groups. J. Ultrasound Med. 31(6), 915–920 (2012)PubMed
23.
Zurück zum Zitat C.N. Chen, J.J. Lin, H. Lee, Y.M. Cheng, K.J. Chang, F.J. Hsieh, H.S. Lai, C.C. Chang, P.H. Lee, Association between color Doppler vascularity index, angiogenesis-related molecules, and clinical outcomes in gastric cancer. J. Surg. Oncol. 99(7), 402–408 (2009)PubMedCrossRef C.N. Chen, J.J. Lin, H. Lee, Y.M. Cheng, K.J. Chang, F.J. Hsieh, H.S. Lai, C.C. Chang, P.H. Lee, Association between color Doppler vascularity index, angiogenesis-related molecules, and clinical outcomes in gastric cancer. J. Surg. Oncol. 99(7), 402–408 (2009)PubMedCrossRef
24.
Zurück zum Zitat A.C. Fleischer, K.J. Niermann, E.F. Donnelly, T.E. Yankeelov, K.M. Canniff, D.E. Hallahan, M.E. Rothenberg, Sonographic depiction of microvessel perfusion: principles and potential. J. Ultrasound Med. 23(11), 1499–1506 (2004)PubMed A.C. Fleischer, K.J. Niermann, E.F. Donnelly, T.E. Yankeelov, K.M. Canniff, D.E. Hallahan, M.E. Rothenberg, Sonographic depiction of microvessel perfusion: principles and potential. J. Ultrasound Med. 23(11), 1499–1506 (2004)PubMed
25.
Zurück zum Zitat A. Lyshchik, R. Moses, S.L. Barnes, T. Higashi, R. Asato, M.I. Miga, J.C. Gore, A.C. Fleischer, Quantitative analysis of tumor vascularity in benign and malignant solid thyroid nodules. J. Ultrasound Med. 26(6), 837–846 (2007)PubMed A. Lyshchik, R. Moses, S.L. Barnes, T. Higashi, R. Asato, M.I. Miga, J.C. Gore, A.C. Fleischer, Quantitative analysis of tumor vascularity in benign and malignant solid thyroid nodules. J. Ultrasound Med. 26(6), 837–846 (2007)PubMed
26.
Zurück zum Zitat H.H. Chen, K.C. Lu, C.J. Lin, C.J. Wu, Role of the parathyroid gland vascularization index in predicting percutaneous ethanol injection efficacy in refractory uremic hyperparathyroidism. Nephron Clin Pract 117(2), c120–c126 (2011)PubMedCrossRef H.H. Chen, K.C. Lu, C.J. Lin, C.J. Wu, Role of the parathyroid gland vascularization index in predicting percutaneous ethanol injection efficacy in refractory uremic hyperparathyroidism. Nephron Clin Pract 117(2), c120–c126 (2011)PubMedCrossRef
27.
Zurück zum Zitat H.A. Pan, M.H. Wu, Y.C. Cheng, L.H. Wu, F.M. Chang, Quantification of ovarian stromal Doppler signals in poor responders undergoing in vitro fertilization with three-dimensional power Doppler ultrasonography. Am. J. Obstet. Gynecol. 190(2), 338–344 (2004)PubMedCrossRef H.A. Pan, M.H. Wu, Y.C. Cheng, L.H. Wu, F.M. Chang, Quantification of ovarian stromal Doppler signals in poor responders undergoing in vitro fertilization with three-dimensional power Doppler ultrasonography. Am. J. Obstet. Gynecol. 190(2), 338–344 (2004)PubMedCrossRef
28.
Zurück zum Zitat E.K. Kim, C.S. Park, W.Y. Chung, K.K. Oh, D.I. Kim, J.T. Lee, H.S. Yoo, New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. AJR Am. J. Roentgenol. 178(3), 687–691 (2002)PubMedCrossRef E.K. Kim, C.S. Park, W.Y. Chung, K.K. Oh, D.I. Kim, J.T. Lee, H.S. Yoo, New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. AJR Am. J. Roentgenol. 178(3), 687–691 (2002)PubMedCrossRef
29.
Zurück zum Zitat H.J. Moon, J.Y. Kwak, M.J. Kim, E.J. Son, E.K. Kim, Can vascularity at power Doppler US help predict thyroid malignancy? Radiology 255(1), 260–269 (2010)PubMedCrossRef H.J. Moon, J.Y. Kwak, M.J. Kim, E.J. Son, E.K. Kim, Can vascularity at power Doppler US help predict thyroid malignancy? Radiology 255(1), 260–269 (2010)PubMedCrossRef
30.
Zurück zum Zitat H.J. Moon, J.M. Sung, E.K. Kim, J.H. Yoon, J.H. Youk, J.Y. Kwak, Diagnostic performance of gray-scale US and elastography in solid thyroid nodules. Radiology 262(3), 1002–1013 (2012)PubMedCrossRef H.J. Moon, J.M. Sung, E.K. Kim, J.H. Yoon, J.H. Youk, J.Y. Kwak, Diagnostic performance of gray-scale US and elastography in solid thyroid nodules. Radiology 262(3), 1002–1013 (2012)PubMedCrossRef
31.
Zurück zum Zitat M.J. Lee, S.W. Hong, W.Y. Chung, J.Y. Kwak, M.J. Kim, E.K. Kim, Cytological results of ultrasound-guided fine-needle aspiration cytology for thyroid nodules: emphasis on correlation with sonographic findings. Yonsei Med. J. 52(5), 838–844 (2011)PubMedCrossRefPubMedCentral M.J. Lee, S.W. Hong, W.Y. Chung, J.Y. Kwak, M.J. Kim, E.K. Kim, Cytological results of ultrasound-guided fine-needle aspiration cytology for thyroid nodules: emphasis on correlation with sonographic findings. Yonsei Med. J. 52(5), 838–844 (2011)PubMedCrossRefPubMedCentral
32.
Zurück zum Zitat H.J. Moon, E.K. Kim, W.Y. Chung, J.H. Yoon, J.Y. Kwak, Minimal extrathyroidal extension in patients with papillary thyroid microcarcinoma: is it a real prognostic factor? Ann. Surg. Oncol. 18(7), 1916–1923 (2011)PubMedCrossRef H.J. Moon, E.K. Kim, W.Y. Chung, J.H. Yoon, J.Y. Kwak, Minimal extrathyroidal extension in patients with papillary thyroid microcarcinoma: is it a real prognostic factor? Ann. Surg. Oncol. 18(7), 1916–1923 (2011)PubMedCrossRef
33.
Zurück zum Zitat J.Y. Kwak, E.K. Kim, J.H. Youk, M.J. Kim, E.J. Son, S.H. Choi, K.K. Oh, Extrathyroid extension of well-differentiated papillary thyroid microcarcinoma on US. Thyroid 18(6), 609–614 (2008)PubMedCrossRef J.Y. Kwak, E.K. Kim, J.H. Youk, M.J. Kim, E.J. Son, S.H. Choi, K.K. Oh, Extrathyroid extension of well-differentiated papillary thyroid microcarcinoma on US. Thyroid 18(6), 609–614 (2008)PubMedCrossRef
34.
Zurück zum Zitat M. Ying, A. Ahuja, C. Metreweli, Diagnostic accuracy of sonographic criteria for evaluation of cervical lymphadenopathy. J. Ultrasound Med. 17(7), 437–445 (1998)PubMed M. Ying, A. Ahuja, C. Metreweli, Diagnostic accuracy of sonographic criteria for evaluation of cervical lymphadenopathy. J. Ultrasound Med. 17(7), 437–445 (1998)PubMed
35.
Zurück zum Zitat American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, S.J. Mandel, E.L. Mazzaferri, B. McIver, F. Pacini, M. Schlumberger, S.I. Sherman, D.L. Steward, R.M. Tuttle, Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19(11), 1167–1214 (2009)PubMedCrossRef American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, S.J. Mandel, E.L. Mazzaferri, B. McIver, F. Pacini, M. Schlumberger, S.I. Sherman, D.L. Steward, R.M. Tuttle, Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19(11), 1167–1214 (2009)PubMedCrossRef
36.
Zurück zum Zitat D.W. Kim, S.J. Jeon, C.G. Kim, Usefulness of thyroglobulin measurement in needle washouts of fine-needle aspiration biopsy for the diagnosis of cervical lymph node metastases from papillary thyroid cancer before thyroidectomy. Endocrine 42(2), 399–403 (2012)PubMedCrossRef D.W. Kim, S.J. Jeon, C.G. Kim, Usefulness of thyroglobulin measurement in needle washouts of fine-needle aspiration biopsy for the diagnosis of cervical lymph node metastases from papillary thyroid cancer before thyroidectomy. Endocrine 42(2), 399–403 (2012)PubMedCrossRef
37.
Zurück zum Zitat S.B. Edge, C.C. Compton, The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann. Surg. Oncol. 17(6), 1471–1474 (2010)PubMedCrossRef S.B. Edge, C.C. Compton, The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann. Surg. Oncol. 17(6), 1471–1474 (2010)PubMedCrossRef
39.
Zurück zum Zitat R. Gallicchio, S. Giacomobono, D. Capacchione, A. Nardelli, F. Barbato, A. Nappi, T. Pellegrino, G. Storto, Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation? Endocrine 44(2), 426–433 (2013)PubMedCrossRef R. Gallicchio, S. Giacomobono, D. Capacchione, A. Nardelli, F. Barbato, A. Nappi, T. Pellegrino, G. Storto, Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation? Endocrine 44(2), 426–433 (2013)PubMedCrossRef
40.
Zurück zum Zitat G. Conzo, D. Pasquali, G. Bellastella, K. Esposito, C. Carella, A. De Bellis, G. Docimo, M. Klain, S. Iorio, S. Napolitano, A. Palazzo, A. Pizza, A.A. Sinisi, E. Zampella, A. Bellastella, L. Santini, Total thyroidectomy, without prophylactic central lymph node dissection, in the treatment of differentiated thyroid cancer. Clinical retrospective study on 221 cases. Endocrine 44(2), 419–425 (2013)PubMedCrossRef G. Conzo, D. Pasquali, G. Bellastella, K. Esposito, C. Carella, A. De Bellis, G. Docimo, M. Klain, S. Iorio, S. Napolitano, A. Palazzo, A. Pizza, A.A. Sinisi, E. Zampella, A. Bellastella, L. Santini, Total thyroidectomy, without prophylactic central lymph node dissection, in the treatment of differentiated thyroid cancer. Clinical retrospective study on 221 cases. Endocrine 44(2), 419–425 (2013)PubMedCrossRef
41.
Zurück zum Zitat J.A. Goddard, D.L. Steward, Prophylactic central lymph node dissection in differentiated thyroid cancer. Endocrine 44(2), 275–277 (2013)PubMedCrossRef J.A. Goddard, D.L. Steward, Prophylactic central lymph node dissection in differentiated thyroid cancer. Endocrine 44(2), 275–277 (2013)PubMedCrossRef
42.
Zurück zum Zitat L. Wartofsky, D. Van Nostrand, Radioiodine treatment of well-differentiated thyroid cancer. Endocrine 42(3), 506–513 (2012)PubMedCrossRef L. Wartofsky, D. Van Nostrand, Radioiodine treatment of well-differentiated thyroid cancer. Endocrine 42(3), 506–513 (2012)PubMedCrossRef
43.
Zurück zum Zitat D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, S.J. Mandel, E.L. Mazzaferri, B. McIver, F. Pacini, M. Schlumberger, S.I. Sherman, D.L. Steward, R.M. Tuttle, Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19(11), 1167–1214 (2009)PubMedCrossRef D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, S.J. Mandel, E.L. Mazzaferri, B. McIver, F. Pacini, M. Schlumberger, S.I. Sherman, D.L. Steward, R.M. Tuttle, Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19(11), 1167–1214 (2009)PubMedCrossRef
44.
Zurück zum Zitat S. Bonnet, D. Hartl, S. Leboulleux, E. Baudin, J.D. Lumbroso, A. Al Ghuzlan, L. Chami, M. Schlumberger, J.P. Travagli, Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment. J. Clin. Endocrinol. Metab. 94(4), 1162–1167 (2009)PubMedCrossRef S. Bonnet, D. Hartl, S. Leboulleux, E. Baudin, J.D. Lumbroso, A. Al Ghuzlan, L. Chami, M. Schlumberger, J.P. Travagli, Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment. J. Clin. Endocrinol. Metab. 94(4), 1162–1167 (2009)PubMedCrossRef
45.
Zurück zum Zitat D.J. Hicklin, L.M. Ellis, Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J. Clin. Oncol. 23(5), 1011–1027 (2005)PubMedCrossRef D.J. Hicklin, L.M. Ellis, Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J. Clin. Oncol. 23(5), 1011–1027 (2005)PubMedCrossRef
46.
Zurück zum Zitat N. Weidner, J.P. Semple, W.R. Welch, J. Folkman, Tumor angiogenesis and metastasis—correlation in invasive breast carcinoma. N. Engl. J. Med. 324(1), 1–8 (1991)PubMedCrossRef N. Weidner, J.P. Semple, W.R. Welch, J. Folkman, Tumor angiogenesis and metastasis—correlation in invasive breast carcinoma. N. Engl. J. Med. 324(1), 1–8 (1991)PubMedCrossRef
47.
Zurück zum Zitat Y. Choi, K.J. Park, S. Ryu, D.H. Kim, J. Yun, D.K. Kang, M. Chun, Papillary thyroid carcinoma involving cervical neck lymph nodes: correlations with lymphangiogenesis and ultrasound features. Endocr. J. 59(10), 941–948 (2012)PubMedCrossRef Y. Choi, K.J. Park, S. Ryu, D.H. Kim, J. Yun, D.K. Kang, M. Chun, Papillary thyroid carcinoma involving cervical neck lymph nodes: correlations with lymphangiogenesis and ultrasound features. Endocr. J. 59(10), 941–948 (2012)PubMedCrossRef
48.
Zurück zum Zitat C.N. Chen, Y.M. Cheng, J.T. Liang, P.H. Lee, F.J. Hsieh, R.H. Yuan, S.M. Wang, M.F. Chang, K.J. Chang, Color Doppler vascularity index can predict distant metastasis and survival in colon cancer patients. Cancer Res. 60(11), 2892–2897 (2000)PubMed C.N. Chen, Y.M. Cheng, J.T. Liang, P.H. Lee, F.J. Hsieh, R.H. Yuan, S.M. Wang, M.F. Chang, K.J. Chang, Color Doppler vascularity index can predict distant metastasis and survival in colon cancer patients. Cancer Res. 60(11), 2892–2897 (2000)PubMed
49.
Zurück zum Zitat E.L. Mazzaferri, R.L. Young, Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am. J. Med. 70(3), 511–518 (1981)PubMedCrossRef E.L. Mazzaferri, R.L. Young, Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am. J. Med. 70(3), 511–518 (1981)PubMedCrossRef
50.
Zurück zum Zitat K.E. Kim, E.K. Kim, J.H. Yoon, K.H. Han, H.J. Moon, J.Y. Kwak, Preoperative prediction of central lymph node metastasis in thyroid papillary microcarcinoma using clinicopathologic and sonographic features. World J Surg 37(2), 385–391 (2013)PubMedCrossRef K.E. Kim, E.K. Kim, J.H. Yoon, K.H. Han, H.J. Moon, J.Y. Kwak, Preoperative prediction of central lymph node metastasis in thyroid papillary microcarcinoma using clinicopathologic and sonographic features. World J Surg 37(2), 385–391 (2013)PubMedCrossRef
51.
Zurück zum Zitat Y.S. Lim, J.C. Lee, Y.S. Lee, B.J. Lee, S.G. Wang, S.M. Son, I.J. Kim, Lateral cervical lymph node metastases from papillary thyroid carcinoma: predictive factors of nodal metastasis. Surgery 150(1), 116–121 (2011)PubMedCrossRef Y.S. Lim, J.C. Lee, Y.S. Lee, B.J. Lee, S.G. Wang, S.M. Son, I.J. Kim, Lateral cervical lymph node metastases from papillary thyroid carcinoma: predictive factors of nodal metastasis. Surgery 150(1), 116–121 (2011)PubMedCrossRef
52.
Zurück zum Zitat A. Machens, H.J. Holzhausen, H. Dralle, The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma. Cancer 103(11), 2269–2273 (2005)PubMedCrossRef A. Machens, H.J. Holzhausen, H. Dralle, The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma. Cancer 103(11), 2269–2273 (2005)PubMedCrossRef
53.
Zurück zum Zitat R. Katoh, J. Sasaki, H. Kurihara, K. Suzuki, Y. Iida, A. Kawaoi, Multiple thyroid involvement (intraglandular metastasis) in papillary thyroid carcinoma. A clinicopathologic study of 105 consecutive patients. Cancer 70(6), 1585–1590 (1992)PubMedCrossRef R. Katoh, J. Sasaki, H. Kurihara, K. Suzuki, Y. Iida, A. Kawaoi, Multiple thyroid involvement (intraglandular metastasis) in papillary thyroid carcinoma. A clinicopathologic study of 105 consecutive patients. Cancer 70(6), 1585–1590 (1992)PubMedCrossRef
54.
Zurück zum Zitat Y. Ito, C. Tomoda, T. Uruno, Y. Takamura, A. Miya, K. Kobayashi, F. Matsuzuka, K. Kuma, A. Miyauchi, Papillary microcarcinoma of the thyroid: how should it be treated? World J. Surg. 28(11), 1115–1121 (2004)PubMedCrossRef Y. Ito, C. Tomoda, T. Uruno, Y. Takamura, A. Miya, K. Kobayashi, F. Matsuzuka, K. Kuma, A. Miyauchi, Papillary microcarcinoma of the thyroid: how should it be treated? World J. Surg. 28(11), 1115–1121 (2004)PubMedCrossRef
55.
Zurück zum Zitat O. Algin, E. Algin, G. Gokalp, G. Ocakoglu, C. Erdogan, O. Saraydaroglu, E. Tuncel, Role of duplex power Doppler ultrasound in differentiation between malignant and benign thyroid nodules. Korean J Radiol 11(6), 594–602 (2010)PubMedCrossRefPubMedCentral O. Algin, E. Algin, G. Gokalp, G. Ocakoglu, C. Erdogan, O. Saraydaroglu, E. Tuncel, Role of duplex power Doppler ultrasound in differentiation between malignant and benign thyroid nodules. Korean J Radiol 11(6), 594–602 (2010)PubMedCrossRefPubMedCentral
56.
Zurück zum Zitat S. Sancak, A. Hardt, R. Gartner, M. Eszlinger, A. Aslan, F.T. Eren, B.M. Gulluoglu, L.S. Sen, Z. Sever, N.S. Akalin, R. Paschke, Comparison of Color Flow Doppler Sonography (CFDS) and immunohistologic detection of microvessels for the assessment of the malignancy of thyroid nodules. Horm. Metab. Res. 42(9), 670–676 (2010)PubMedCrossRef S. Sancak, A. Hardt, R. Gartner, M. Eszlinger, A. Aslan, F.T. Eren, B.M. Gulluoglu, L.S. Sen, Z. Sever, N.S. Akalin, R. Paschke, Comparison of Color Flow Doppler Sonography (CFDS) and immunohistologic detection of microvessels for the assessment of the malignancy of thyroid nodules. Horm. Metab. Res. 42(9), 670–676 (2010)PubMedCrossRef
Metadaten
Titel
Can increased tumoral vascularity be a quantitative predicting factor of lymph node metastasis in papillary thyroid microcarcinoma?
verfasst von
Hyun Joo Shin
Eun-Kyung Kim
Hee Jung Moon
Jung Hyun Yoon
Kyung Hwa Han
Jin Young Kwak
Publikationsdatum
01.09.2014
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 1/2014
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-013-0131-8

Weitere Artikel der Ausgabe 1/2014

Endocrine 1/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Chronische Verstopfung: „Versuchen Sie es mit grünen Kiwis!“

22.05.2024 Obstipation Nachrichten

Bei chronischer Verstopfung wirken Kiwis offenbar besser als Flohsamenschalen. Das zeigen die Daten aus einer randomisierten Studie, die der Gastroenterologe Oliver Pech beim Praxis-Update vorstellte.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.